Â
Ghana FDA in collaboration with CEPI and PEI are facilitating exposure of ECOWAS countries (with focus on those where Lassa fever is prevalent) to Lassa Fever vaccine development projects by conducting scientific advice and clinical trials application simulations using the AVAREF platform, and foster collaboration between NRAs and Ethics Committees.
Observation of real joint advice and CTA review procedures will provide additional learning opportunities.
The 1st Observation opportunity for ECOWAS regulators of a joint Scientific Advice at the AVAREF platform has been realized on 1st Nov. 2023